Search clinical trials for: BI 905711

Total 1234 results

BioInvent International AB

Active, not recruiting

BI-1607 in Combination With Trastuzumab in Subjects With HER2-positive Advanced Solid Tumors (CONTRAST)

HER2-positive Breast Cancer | HER2-positive Gastric Cancer | Metastatic Gastric Adenocarcinoma | Metastatic Gastroesophageal Junction Adenocarcinoma | HER2-positive Metastatic Breast Cancer

Spain, United Kingdom, Germany
Boehringer Ingelheim

Completed

BI 44370 TA in Acute Migraine Attack

Migraine Disorders

Belgium, El Salvador, France, Germany, Italy, Netherlands, Spain, Sweden, United Kingdom
Boehringer Ingelheim

Completed

Effect of Treatment BI 1744 CL (5 and 10 mcg) Versus Placebo on Exercise Endurance Time During Constant Work Rate Cycle Ergometry II

Pulmonary Disease, Chronic Obstructive

Austria, Belgium, Canada, Germany, Russian Federation
Lawson Health Research Institute

Not yet recruiting

Bi-level vs. Single Level ESB in VATS

Acute Pain

Canada
Boehringer Ingelheim

Completed

A Study to Test How Taking BI 1015550 for 12 Weeks Affects Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)

Idiopathic Pulmonary Fibrosis

Spain, United States, Canada, Korea, Republic of, Australia, Italy, United Kingdom, Germany, China, Finland, Denmark, Netherlands, Greece, Argentina, Austria, Chile, Czechia, Hungary, Japan, Poland, Russian Federation, Ukraine
Boehringer Ingelheim

Completed

Relative Bioavailability of Multiple Oral Doses of BI 187004 and Metformin After Co-administration Compared to Multiple Oral Doses of BI 187004 Alone and Metformin Alone in Healthy Male Subjects

Healthy

Germany
Boehringer Ingelheim

Completed

Effectiveness and Safety of Different Doses of BI 1026706 in Patients With Postoperative Dental Pain

Pain, Postoperative

Italy
Boehringer Ingelheim

Completed

Investigation of the Metabolism and Pharmacokinetics of [14C]BI 1744 CL and [14C]BI 1744 CL Administered as an Oral Solution in Healthy Male Subjects

Healthy
Boehringer Ingelheim

Completed

Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-naïve Genotype 1 Hepatitis C Infected Patients (STARTverso 1)

Hepatitis C

Austria, Belgium, France, Germany, Japan, Portugal, Romania, Russian Federation, Spain, Switzerland, United Kingdom
Nanjing Medical University

Completed

Auto-trilevel Ventilator for Patients With Overlap Syndrome

Overlap Syndrome

China
Boehringer Ingelheim

Completed

Effects of BI 44370 TA Orally Applied as Tablets on the Pharmacokinetics of Orally Administered Midazolam Solution in Healthy Volunteers

Healthy
Boehringer Ingelheim

Completed

BI 811283 in Combination With Cytarabine in Previously Untreated AML Ineligible for Intensive Treatment

Leukemia, Myeloid, Acute

Germany
University of Miami
Florida

Completed

Effects of Bodily Illusion and tDCS on SCI-related Neuropathic Pain

Neuropathic Pain

United States
Bill & Melinda Gates Medical Research Institute

Active, not recruiting

Impact of Bi-26 Supplementation on Weight Gain in Underweight Infants

Underweight | Paediatrics

Pakistan
Boehringer Ingelheim

Completed

Clinical Characteristics and Practice Patterns of Type 2 Diabetes Mellitus Patients Treated With OADs in Japan: Analysis of Medical and Health Care Database of the MDV

Diabetes Mellitus, Type 2

Japan
Northern Orthopaedic Division, Denmark

Completed

Bimetric-10: Investigation of Patients Who Have Underwent Total Hip Arthroplasty With a Cemented Bi-Metric Stem

Osteoarthrosis

Denmark
Boehringer Ingelheim

Completed

Single Dose of BI 1744 CL in Patients With Mild and Moderate Hepatic Impairment Compared to Subjects With Normal Hepatic Function

Liver Diseases | Healthy
Boehringer Ingelheim

Completed

Pharmacokinetics of BI 409306 After a High Fat, High Caloric Meal and After a Single Oral Dose Given at Bed Time in Healthy Volunteers

Healthy

Germany
Ann & Robert H Lurie Children's Hospital of Chicago
National Institute on Drug Abuse (NIDA)

Completed

Employing eSBI in HIV Testing for At-risk Youth

HIV | Substance Use

United States
ResMed

Completed

Effectiveness of Adaptive Servoventilation (ASV) in Patients With Central Sleep Apnea Due to Chronic Opioid Use

Obstructive Sleep Apnea | Central Sleep Apnea (Diagnosis) | Chronic Opioid Use

United States
Boehringer Ingelheim

Completed

A Phase I Trial to Investigate the Metabolism and Pharmacokinetics as Well as Safety and Tolerability of a Single Dose BI671800 HEA Administered as an Oral Solution of the Choline Salt in Healthy Male Volunteers

Healthy

United States
Boehringer Ingelheim

Completed

Intravenous BI 836826 in Combination With Ibrutinib in Relapsed/Refractory CLL Patients Who Have Been Pre-treated With at Least One Prior Line of Systemic Therapy, and Who Are Eligible for Treatment With Ibrutinib

Leukemia, Lymphocytic, Chronic, B-Cell

United States
University of Minnesota

Completed

Lose 2 Win A Novel Method to Motivate Weight Loss Maintenance Among College Students (L2W)

Overweight | Obese

United States
Hospital Sao Joao
Marta Drummond MD PhD; Joao Carlos Winck MD PhD; Mafalda van Zeller MD Phstud

Unknown

Continuous Positive Pressure Versus Bi-level in Overlap Syndrome

Overlap Syndrome | Nocturnal Hypoventilation
Boehringer Ingelheim

Completed

Phase 3 Study of BI 207127 in Combination With Faldaprevir and Ribavirin for Treatment of Patients With Hepatitis C Infection, Including Patients Who Are Not Eligible to Receive Peginterferon: HCVerso2

Hepatitis C, Chronic

United States, Australia, Belgium, Canada, France, Germany, Greece, Italy, New Zealand, Portugal, Spain, United Kingdom
Boehringer Ingelheim

Completed

Rel. BA of Empagliflozin (BI 10773)/Linagliptin FDC Tbl, Comparison With Mono-components, With a Second FDC Tablet and Influence of Food

Healthy

Germany
Boehringer Ingelheim

Recruiting

A Study to Test Whether Multiple Doses of BI 456906 Have an Effect on Cardiac Safety in People With Overweight or Obesity

Obesity | Overweight

Germany
University of California, San Diego

Recruiting

The Cardiovascular Consequences of Sleep Apnea Plus COPD (Overlap Syndrome) (CRESCENDO-SLP)

Chronic Obstructive Pulmonary Disease | Obstructive Sleep Apnea | Overlap Syndrome

United States
Universiteit Antwerpen
Amref Health Africa

Completed

Effect of Onchocerciasis Elimination Measures on the Incidence of Epilepsy in Maridi, South Sudan (OAEMaridi)

Epilepsy | Onchocerciasis

South Sudan
Hospices Civils de Lyon

Completed

Endoscopic Sub-mucosal Dissection With the Nestis® Jet Injector System With a Bi-functional Catheter: First Prospective Trial (NESTIS)

Colorectal Neoplasms | Barrett's Esophagus | Intestinal Dysplasia | Esophageal Dysplasia

France
Boehringer Ingelheim

Completed

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Rising Doses of BI 409306

Healthy

Germany
Boehringer Ingelheim

Completed

BI 409306 Cardiac Safety Trial in Healthy Volunteers

Healthy

Germany
FHI 360
United States Agency for International Development (USAID)

Completed

Alcohol Harm Reduction Intervention Among Female Sex Workers in Mombasa, Kenya

Alcohol Use and STI/HIV Infections, Domestic Violence

Kenya
Boehringer Ingelheim

Completed

The VOLTAIRE-X Trial Looks at the Effect of Switching Between Humira® and BI 695501 in Patients With Plaque Psoriasis

Psoriasis

United States, Poland, Hungary, Germany, Latvia, Russian Federation, Ukraine
Boehringer Ingelheim

Completed

A Study to Test How Well Healthy Men Tolerate Different Doses of BI 764198

Healthy

Germany
Boehringer Ingelheim

Withdrawn

This Study in Patients With Chronic Lymphocytic Leukaemia is Done to Determine a Safe and Effective Dose of BI 836826 in Combination With Venetoclax

Leukemia, Lymphocytic, Chronic, B-Cell
Boehringer Ingelheim

Completed

Phase III Trial of BI 201335 (Faldaprevir) in Treatment Naive (TN) and Relapser Hepatitis C Virus (HCV)-Human Immunodeficiency Virus (HIV) Coinfected Patients (STARTverso 4)

Hepatitis C, Chronic

United States, Brazil, France, Germany, Italy, Spain, Switzerland, United Kingdom
Wissenschaftliches Institut Bethanien e.V

Completed

Validation of a New Automatic Bi-level Algorithm in the Treatment of Sleep-disordered Breathing

Obstructive Sleep Apnea

Germany
Boehringer Ingelheim

Completed

Thorough QT Study to Evaluate the Effects of BI 207127 (Deleobuvir) Combined With Faldaprevir on Cardiac Safety Parameters in Healthy Subjects.

Healthy

Germany
Boehringer Ingelheim

Completed

Safety and Tolerability of BI 409306 in Patients With Schizophrenia

Schizophrenia

United States
University of British Columbia

Completed

Comparing 2L Bi-Pegyte to 4L PegLyte Regiments for Outpatient Colonic Preparation

Efficacy of Bowel Preparation | Ease of Bowel Preparation and Patient Tolerability

Canada
The Hong Kong Polytechnic University

Recruiting

Upper Limb Mirror Therapy With Bilateral Transcutaneous Electrical Nerve Stimulation to Improve Upper Limb Functions in Patients With Stroke

Stroke

Hong Kong
University of Pennsylvania

Completed

Post-op Crowd Sourcing Health Data Via Text-messaging

Surgery | Opioid Use | Orthopedic Surgery | Neurosurgery | Acute Injuries Knee

United States
Universitaire Ziekenhuizen KU Leuven
Johnson & Johnson

Active, not recruiting

Longitudinal Follow-up of Male Soccer Players Prone to Developing CAM Hip Deformity (CAM-FAI)

Femoro Acetabular Impingement | CAM

Belgium
Organon and Co

Completed

Japanese Bridging Trial of Org 37462 (Study P05969)(COMPLETED)

Controlled Ovarian Stimulation
Texas Woman's University

Not yet recruiting

Benefits of Insoles With Real-Time Alert and Foot Self-Care Education

Diabetes Complications

United States
Boehringer Ingelheim

Completed

Assessment of Exposure of BI 409306 in Cerebrospinal Fluid (CSF) Relative to Plasma as Well as to Evaluation of the Effect of Different Doses of BI 409306 on the cGMP (Cyclic Guanosine Monophosphate) Levels in CSF in Healthy Male Volunteers

Healthy

Belgium
Boehringer Ingelheim

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Doses

Healthy

Germany
Boehringer Ingelheim

Completed

BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis

Arthritis, Rheumatoid

Spain, United States, Korea, Republic of, Malaysia, Poland, Thailand, Bulgaria, Chile, Estonia, Germany, Hungary, New Zealand, Russian Federation, Serbia, Ukraine
University of California, San Francisco

Completed

The Effect of a Novel Audit and Feedback Bundle on Inpatient Performance

Quality Improvement

United States

3

Subscribe